Alcon has launched TobraDex ST (tobramycin 0.3%/dexmethasone 0.05%), a combination anti-inflammatory/anti-infective ophthalmic suspension. TobraDex ST is indicated for steroid-responsive inflammatory ocular conditions where superficial bacterial ocular infection or a risk of infection exists.